NIH to evaluate remdesivir treatment for COVID during pregnancy

WASHINGTON (NEWS10) — The National Institutes of Health (NIH) is funding a study into the effects of prescription remdesivir on those who are both pregnant and COVID-positive. Called “IMPAACT 2032,” the study, conducted at 17 sites in the U.S., will examine how pregnant people metabolize and digest the drug, and whether it poses side effects. […]

Phase III Trial to Study Combination of Genentech's Actemra

2020 Archive - UM School of Medicine Researchers Test Remdesivir

Clinical outcomes of hospitalized COVID-19 patients treated with

Favipiravir, camostat, and ciclesonide combination therapy in

Outpatient Treatment Options for Acute COVID-19 ​

The Incidence, Severity, and Management of COVID-19 in Critically

Coronavirus Drug and Treatment Tracker - The New York Times

Remdesivir for pregnancy: A systematic review of antiviral therapy

Critical study of Gilead drug shows coronavirus patients

Remdesivir in pregnant women with moderate to severe coronavirus